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Abstract
Background: An individualized patient reported outcome (PRO) has recently been recommended within LBP
research, but no study has evaluated this instrument with commonly applied PROs. Moreover, the impact of
psychological factors has mostly been assessed for disease-specific instruments. The objective of this study was
to assess the predictive value of illness perceptions, pain catastrophizing and psychological distress on 12 month
outcomes assessed by specific, generic and individualized PROs recommended in low back pain (LBP).
Methods: Secondary analysis of patients with sub-acute or chronic LBP recruited for a cluster randomized
controlled trial in primary care who completed a self-administered questionnaire at baseline and 12 months.
12 month scores for the Roland Morris Disability Questionnaire (RMDQ), the EuroQol (EQ-5D), and the Patient
Generated Index (PGI) were dependent variables in hierarchical regression analysis. Independent variables included
baseline scores for the Brief Illness Perceptions Questionnaire (Brief IPQ), Hopkins Symptom Check List (HSCL-25),
Pain Catastrophizing Scale (PCS), health/clinical and sociodemographic variables.
Results: Of the 216 eligible patients included, 203 patients responded to the baseline questionnaire and 150 (74%)
responded at 12 months. The mean age was 38.3 (SD 10.2) years and 57.6% were female. The Brief IPQ showed a
statistically significant variation in the 12-months score of all the PROs, explaining 2.5% in RMDQ, 7.9% in EQ-5D,
and 3.6% in PGI. Most of the explained variation for EQ-5D scores related to illness perceptions. The PCS explained
3.7% of the RMDQ and 2.5% in the EQ-5D scores. The HSCL-25 did not make a significant contribution.
Conclusion: Illness perceptions and pain catastrophizing were associated with 12-month outcomes as assessed by
condition-specific, generic and individualized PROs. The Brief IPQ and PCS have relevance to applications in primary
care that include interventions designed to enhance psychological aspects of health and where the contribution of
such variables to outcomes is of interest. Further studies should assess whether the Brief IPQ perform similarly in
LBP populations in other health care settings.
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Background
The identification of key prognostic factors is an import-
ant research area in low back pain (LBP) [1, 2]. This in-
cludes psychological factors which being modifiable, have
relevance to clinical settings and guidelines recommend
their assessment when treating patients [3, 4]. The most
widely explored psychological factors are distress, fear
avoidance beliefs and pain catastrophizing [5–7]. However,
a recent systematic review evaluating which psychological
factors might be associated in the transition from acute to
chronic LBP in primary care, concluded that these psycho-
logical factors show modest predictive ability on outcomes
including disability, pain and work status [6]. Illness
perceptions is another psychological construct that has re-
ceived increasing attention in back pain research but few
independent prospective studies have assessed its role as a
predictor of scores for patient reported outcomes (PROs)
[8–11]. One study that compared the predictive ability of
20 psychological constructs in LBP, including fear avoid-
ance beliefs, pain catastrophizing, and distress found that
illness perceptions was the best predictor of disability at
six months [9]. Aspects of illness perceptions also best
predicted outcome at five years in this patient group [11].
The impact of psychological factors has largely focused
on disease-specific PRO instruments including the Roland-
Morris Disability Questionnaire (RMDQ) [5, 6]. Instru-
ments assessing broader constructs including general health
status and quality of life have received less attention, as
reflected in their less frequent inclusion in reviews of the
impact of psychological factors on LBP [5, 6]. Recent con-
cerns have been raised that other types of outcomes which
are important to back pain patients, are not part of the rec-
ommended outcome core set for back pain [12–14]. Sleep,
social factors, fatigue and emotional well-being are areas
found to be more important to patients with LBP than cur-
rently recognized [12–14]. This has led to the recommen-
dation that an individualized measure of quality of life, the
Patient Generated Index (PGI), should be included along-
side the core set of outcome measures [13]. Individualized
instruments allow the patient to select areas of importance
to them. Hence their inclusion means that patients have
the opportunity to include aspects of life that are not
included in standardized instruments, but considered im-
portant in outcome assessment [15, 16]. PRO instruments
that assess outcomes of importance to the individual pa-
tient complement clinical and health services evaluation
and promote health outcomes more generally. It has also
been argued that the absence of areas of less relevance re-
duces the level of ‘noise’ present in standardized instru-
ments which can improve methodological aspects of
outcomes, including responsiveness to change [17, 18].
The objective of this study was to assess the impact of
illness perceptions, pain catastrophizing and psycho-
logical distress on recommended back pain PROs
12 months after an episode of non-specific LBP. The
PROs included two of the most widely used instruments
in patients with back pain, the RMDQ and the EQ-5D,
and the recently recommended individualized PGI which
has been validated in LBP [16].
Methods
Design and setting
This a-priori planned secondary analysis of a cluster ran-
domized controlled trial [19, 20], included 220 patients
recruited between 2008–2012 from general practitioners
(GPs) and physiotherapists (PTs). The clinicians were
randomly assigned to either provide a cognitive patient
education intervention, based on the understanding of the
physiology of pain or usual care. Treatment was provided
once a week in one to one 30 min sessions for up to four
consecutive weeks in the clinicians’ usual primary care set-
tings, located in the greater Oslo area. We refer to the
study protocol for further details on recruitment and
treatment [19]. We followed recommendations and guide-
lines for reporting a multivariate prediction model where
appropriate for this study [1, 21].
Data collection
Clinicians recruited patients with non-specific LBP last-
ing 4–52 weeks, aged 20–55 years old with a score of ≥ 4
on the RMDQ. Exclusion criteria were possible nerve
root pain or severe pathology, “red flags” or demand for
a specific treatment. Following informed consent, the
baseline questionnaire was completed in the provider’s
waiting room or at home. Patients received a 12 month
follow-up postal questionnaire.
The study was approved by the Norwegian Regional
Committee for Medical Research Ethics East and the
Data Inspectorate and followed the Helsinki Declaration.
Outcomes and psychological instruments
The self-completed questionnaire included the PRO and
psychological instruments, numerical rating scale of
back pain (0–10) and questions relating to age, sex, eth-
nicity (born in Norway- yes/no), education (≤12 years/>
12 years), employment (employed/student/unpaid work
or unemployed/rehabilitation/sickleave), smoking (yes/
no), co-morbidity (yes/no), BMI, previous LBP (yes/no).
PRO instruments included disability in daily activities
assessed by the RMDQ, which has 24 yes/no items that
sum to a score from 0–24, where 24 is the most severe
back related disability [22]. The RMDQ has evidence for
data quality, reliability and validity in Norwegian LBP
patients [23].
General health status was assessed by the EQ-5D [24]
3-L version which is a utility instrument with five items
that have three-point descriptive scales of no problem,
some problems and severe problems. The EQ-5D index
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is based on utility weights from the general population
and is scored from −0.59 to 1.0 were 1 is the best pos-
sible score. The EQ-5D has evidence for reliability and
validity in Norwegian LBP patients [25].
Individual quality of life was assessed by the PGI com-
pleted in three stages [16, 26]. In the first stage, patients
list up to five important areas in their life affected by
their LBP. In the second, they rate the extent to which
their LBP has affected them in each area and in the rest
of their lives on a seven point scale from “the worst they
can imagine” to “exactly as they would like it to be”. In
the third stage they are asked to imagine that they can
improve some or all of the areas with ten points to dis-
tribute across the areas that they would most like to im-
prove. The PGI score from 0–100 represents the worst
and best possible quality of life respectively. The PGI
has evidence for reliability and validity in Norwegian pa-
tients with LBP [16].
Three psychological instruments were included as pre-
dictors. Illness perceptions was assessed by the Brief Ill-
ness Perceptions Questionnaire (Brief IPQ) [27] which has
nine items comprising cognitive and emotional illness
perceptions. The items have a 0–10 scale with endpoint
descriptors. The items sum to give a score from 0 to 100
with higher scores representing a more threatening view
of illness. The instrument has evidence for reliability and
validity in Norway [28].
Psychological distress was assessed by the Hopkin’s
Symptom Check List (HSCL-25), which has 25 items [29].
The HSCL-25 asks about symptoms during the last week
and items have a four-point scale from “not at all” to “to a
large extent”. Items sum to give a score from 0 to 4 where
4 is the most severe symptoms. The Norwegian HSCL-25
version has been used in several studies, including patients
with LBP [30–32], however evidence relating to reliability
and validity in patients with LBP is lacking.
Pain catastrophizing was assessed by the 13-item Pain
Catastrophizing Scale (PCS) [33] which asks about past
painful experiences and the degree to which they experi-
enced this on a five-point scale from “not at all” to “all
the time” (31). Items sum to give a score from 0 to 52
where 52 is the highest level of catastrophizing. The PCS
has evidence for reliability and validity in Norwegian pa-
tients with LBP [34].
Statistical analysis
Hierarchical multiple regression analysis [35] was used
to assess the contribution of baseline Brief IPQ, HSCL-
25 and PCS scores to those for the 12 months RMDQ,
EQ-5D and PGI scores, after controlling for baseline
sociodemographic and health/clinical variables. Univari-
ate analysis informed variable selection and hence the
three models differ slightly. Variables that made a signifi-
cant contribution at the p < 0.10 level to the dependent
variables were included in the final multivariate regres-
sion analysis in addition to sex, age, type of treatment
and type of clinician. Sample size requirements took into
account the number of independent variables used (N >
50+ 8 m) [36]. The assumptions of regression analysis
were assessed including normality, presence of outliers
and no multicollinearity. Normal probability plots were
examined and the correlation between the independent
variables assessed [36]. Sociodemographic variables were
entered in the first step, health status and clinical
variables in the second, and each of the psychological in-
struments was entered in the third to fifth steps. PGI
scores at follow-up are usually based on stage three
points at follow-up administration. However, for pur-
poses of intervention studies it is recommended that
baseline points are used which reflect the patients ori-
ginal priorities for improvement [34]. Therefore, a sensi-
tivity analysis was conducted with this alternative
method of scoring the PGI also as dependent variable.
The 5% significance level was used.
SPSS version 21 was used for all the statistical analysis.
Results
Data collection
Of the 220 patients, four were excluded because they
were retrospectively found not to meet the inclusion cri-
teria. Of the 216 eligible patients, 203 patients
responded to the baseline questionnaire and 150 (74%)
at 12 months. The most frequent reason for loss at
follow-up was lack of response to reminders by mail or
telephone. Compared to responders, non- responders at
12 months had higher BMI (p < 0.01), a lower education
level (p < 0.05) and a greater proportion received treat-
ment from GPs compared to PTs (p < 0.05).
Table 1 shows the patients sociodemographic characteris-
tics and mean scores for the PRO instruments. Table 2
shows the univariate analysis of the contribution of baseline
variables to the three types of PROs at 12 months. There
was no deviation from normality, evidence of outliers or
multicollinearity in the multivariate analyses. Table 3 shows
the results of the hierarchical multiple regressions analyses
with the RMDQ as dependent variable at 12 months. Two
of the three psychological instruments significantly contrib-
uted to explaining variation in RMDQ scores separately;
2.5% and 3.7% for the Brief IPQ and PCS respectively
(Table 3, models 3–5). Health /clinical variables explained
12.2% of the variation (model 2). The model that explained
the highest percentage of variation at 25.6% included the
PCS, health/clinical and sociodemographic variables.
The PCS and the Brief IPQ also made significant con-
tributions to explaining variation in EQ-5D scores separ-
ately; 2.5% for the PCS and 7.9% for the Brief IPQ
(Table 4, models 3–5). Independently, Brief IPQ scores
(7.9%) explained about the same amount of variation in
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EQ-5D as the sociodemographic (7.5%) and health/clin-
ical (7.2%) variables. The model that explained the high-
est percentage of variation at 22.6% included the Brief
IPQ, health/ clinical and sociodemographic variables.
The Brief IPQ was the only psychological instrument
that explained a statistically significant component
(3.6%) of the variation in the PGI, which was similar to
that for the health status and clinical variables (Table 5).
The model that explained the highest percentage of vari-
ation at 8.1% included the Brief IPQ, health/clinical and
sociodemographic variables. The use of PGI baseline
stage three points did not affect the results (not shown).
The HSCL-25 did not make a significant contribution
in any of the multivariate analyses (Tables 3, 4 and 5).
Discussion
The aim of this study was to assess the impact of illness
perceptions, pain catastrophizing and psychological dis-
tress on PROs recommended for back pain 12 months
after an episode of non-specific LBP. Illness perceptions at
baseline predicted 12 months scores for the three types of
PROs: the disease-specific RMDQ, the generic EQ-5D and
the individualised PGI. Pain catastrophizing predicted
12 months RMDQ and EQ-5D scores, but not those for
the PGI. Finally, psychological distress did not show any
significant association with any of the 12 month PRO
scores. In prognostic LBP studies, baseline factors
typically account for around 30% of the variation in
outcome [37], with psychological aspects, explaining
less than 5% in disease-specific outcomes including
the RMDQ and the Oswestry Disability Index (ODI)
[9, 10, 30]. The current findings for the impact of
pain catastrophizing and illness perceptions on the
RMDQ are in agreement with this literature.
The strongest association in the current study was
between illness perceptions and 12-months scores of EQ-
5D. Illness perceptions explained nearly 8% of the variation
in 12-months EQ-5D. Moreover, illness perceptions was
the only psychological factor that showed a significant im-
pact on health-related quality of life, as assessed by the in-
dividualized PGI (3.6%). There are few published studies,
which have evaluated the impact of illness perceptions on
quality of life instruments. With the exception of one study
that included the Short Form Health Survey (SF-36) as an
outcome measure (10) and found that illness perceptions
explained up to 14% of the variance, the proportion of vari-
ance explained by illness perceptions in the current study
as assessed by the EQ-5D (8%) is greater than previously
reported [9]. Our results are in agreement with previous
studies showing that illness perceptions have been found
to be associated with health outcomes of disability, pain
and general health [9, 10]. Minor differences might be ex-
plained by the fact that the current study included the Brief
IPQ with a sum scale of illness perceptions, whereas the
Table 1 Patient characteristics for patients responding to the






Age years (mean, SD) 38.3 (10.2)




Medical doctor 62 (30.5)
Physiotherapist 141 (69.5)
Type of treatment (n, %)
Usual care 100 (49.3)
Cognitive intervention 103 (50.7)
Education level
12 years or less 54 (26.7)
> 12 years 148 (73.3)













Back pain, NRS (0–10) 5.1 (2.1)
Brief-IPQ (mean, SD)a 52.5 (12.4)
PCS (mean, SD)b 15.9 (9.2)
HSCL-25 (mean, SD)c 1.6 (0.4)
Outcome variables
RMDQ (mean, SD)d 9.3 (4.0)
EQ-5D (mean, SD)e 0.6 (0.3)
PGI (mean, SD)f 38.4 (14.8)
aBrief-IPQ (0–100); higher scores represent a more threatening view of
the illness
bPCS (0–52); higher scores represent higher levels of catastrophizing
cHSCL-25 (1–4); higher scores represent more severe symptoms
dRMDQ (0–24); higher scores represent greater overall disability
eEQ-5D (−0.59 to 1.0); higher scores represent better health status
fPGI (0–100); higher scores represent better quality of life
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other studies in LBP have used longer versions, without a
sum scale [38]. The greater proportion of variation ex-
plained by illness perceptions when the EQ-5D was the
dependent variable might be due to the broader focus of
the EQ-5D as compared to the RMDQ with its focus on
back-related disability. It would be interesting to consider
the role of illness perceptions and pain catastrophizing in
explaining other back-related and generic PROs.
Baseline PCS scores were significantly associated with
disability as assessed by the RMDQ (3.7%) and general
health as assessed by the EQ-5D (2.5%) at 12 months.
A recent systematic review evaluating catastrophizing
as a prognostic factor in LBP concluded that there is
some evidence that catastrophizing as a coping strat-
egy might lead to delayed recovery but that the influ-
ence of catastrophizing in patients with LBP is not
fully established [39].
Distress did not explain any significant variation in the
outcome measures included in our study. Previous system-
atic reviews that included psychological factors as predic-
tors of outcomes in prospective cohorts of patients with
LBP or musculoskeletal pain, point to an association be-
tween distress and PROs [5, 40]. The studies included in
the reviews had outcomes relating to symptom satisfaction,
the RMDQ and pain. A recent review found evidence for
the predictive ability of distress in two of seven studies in
primary care [6]. Different measures used to assess these
concepts as well as different patient populations and PRO
instruments may explain the variation across studies.
The independent variables included in the current study
reflect the bio-psycho-social model where potentially im-
portant sociodemographic, health and clinical variables
were included in the univariate analysis. The variables in-
cluded in the final model explained between 22.6% and
Table 2 Univariate analysis of the contribution of baseline variables to three types of patient-reported outcomes; the diseases-
specific RMDQ, the generic EQ-5D scores and the individualized PGI at 12 months
Variables RMDQe 12 m EQ-5Df 12 m PGIg 12 m
(n = 147) (n = 150) (n = 137)
R2 βa p- value R2 β a p- value R2 βa p- value
Sociodemographic
Sex (women = 2) .004 -.506 .433 .000 -.005 .912 .005 3.222 .421
Age years .000 -.002 .940 .000 -.001 .791 .000 .004 .982
Ethnicity (Norwegian) (yes/no) (no = 2) .040 2.118 .016 .023 -.105 .066 .009 −6.148 .264
Education level (>12 years = 2) .046 −1.863 .009 .049 .126 .006 .015 6.453 .148
Employment status (employed/ unemployed) (unemployed =2) .017 1.023 .115 .021 -.073 .079 .006 3.724 .356
Smoking (yes/no) (yes = 2) .020 1.780 .088 .014 -.098 .145 .004 −4.476 .491
Health/clinical
BMI .017 .121 .116 .009 -.006 .250 .016 -.696 .143
Previous LBP (yes/no) (yes = 2) .005 .764 .401 .002 -.035 .554 .000 -.224 .968
Back pain (NRS) (0–10) .042 .382 .013 .034 -.022 .024 .023 −1.711 .076
Co-morbidity (yes/no) (yes = 2) .000 .136 .833 .000 -.004 .928 .007 −3.789 .344
Clinical setting (Medical Doctor/ Physio) (MD = 2) .085 2.402 .000 .053 -.123 .005 .014 −5.915 .162
Treatment (usual care/cognitive) (usual care = 2) .008 -.697 .274 .002 .024 .552 .002 1.878 .635
Psychological
Brief-IPQb (0–100) .146 .118 .000 .185 -.009 .000 .068 -.483 .002
HSCL-25c (1–4) .055 2.065 .004 .062 -.143 .002 .025 −8.419 .063
PCSd (0–52) .148 .162 .000 .097 -.009 .000 .033 -.456 .034
Outcome variables
RMDQe baseline (0–24) .097 .301 .000 .060 -.015 .003 .004 -.386 .437
EQ-5Df baseline (−0.59-1) .097 −4.536 .000 .082 .272 .000 .021 12.589 .092
PGIg baseline (0–100) .013 -.030 .182 .006 .001 .391 .007 .134 .336
aUnstandardized beta
bBrief-IPQ; higher scores represent a more threatening view of the illness
cPCS; higher scores represent higher levels of catastrophizing
dHSCL-25; higher scores represent more severe symptoms
eRMDQ; higher scores represent greater overall disability
fEQ-5D; higher scores represent better health status
gPGI; higher scores represent better quality of life
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25.6% for the EQ-5D and RMDQ respectively, which is
consistent with other prospective studies [37]. There are
no published studies that have examined the association
between the independent variables included in this study
and individualised outcomes as assessed by instruments
such as the PGI. In the current study, only 5 of the 18 var-
iables included in the univariate analysis were significantly
associated with PGI scores at the 10% level and only ill-
ness perceptions explained statistically significant variation
at the 5% level in the final model. The final model only ex-
plained 8.1% of the variation. Different options are avail-
able for administering the PGI at baseline and follow-up.
The current study followed the latest recommendations
by one of the developers including a closed format for the
areas in stage one [41]. Following recent recommenda-
tions [41], a sensitivity analysis was conducted with the
points given in stage three at baseline included at follow-
up. The sensitivity analysis did not influence the results.
The reliability and validity of the instruments included as
dependent and independent variables places an upper
limit on the size of the associations expected in both the
current and previous studies. The Brief IPQ and PCS have
evidence for these measurement properties in this group
of patients [28, 34], but evidence is lacking for the HSCL-
25 in Norwegian back pain patients. However, these con-
siderations are relatively minor given the relatively low
level of associations expected based on existing research
of psychological prognostic factors [9, 10, 30].
Table 4 Final hierarchical linear regression analysis of the relationship between EQ-5D and the psychological scales adjusted for
sociodemographic and health/clinical variables (n = 150)
R2 R2 change β a 95% CI for B St. β p-value
Variables
Model 1: sociodemographicb 7.5% 7.5%
Model 2: health/clinicalc 14.7% 7.2%
Model 3: illness perceptionsd 22.6% 7.9%
Brief-IPQ (0–100) -.007 -.011 to -.003 -.345 .000
Model 4: pain catastrophizinge 17.2% 2.5%
PCS (0–52) -.005 -.010 to.000 -.184 .045
Model 5: psychological distressf 15.3% 0.6%
HSCL-25 (1–4) -.056 -.166 to.054 -.098 .316
a Unstandardized Beta
bModel 1: sex, age, ethnicity, education and employment
cModel 2: back pain (NRS 1–10), baseline RMDQ, baseline EQ-5D, clinical setting (GP or PT) and type of treatment (usual care or cognitive intervention) in addition
to the sociodemographic variables in model 1
dModel 3: illness perceptions by the Brief IPQ (sum score) in addition to the variables in model 1 and 2
eModel 4: pain catastrophizing by the PCS (sum score) in addition to the variables in model 1 and 2
fModel 5:) psychological distress by the HSCL-25 (sum score) in addition to the variables in model 1 and 2
Table 3 Final hierarchical linear regression analysis of the relationship between RMDQ on the psychological instrument scores,
health, clinical and sociodemographic variables (n = 147)
R2 R2 Change β a 95% CI for B St. β p-value
Variables
Model 1: sociodemographicb 9.7% 9.7%
Model 2: health/clinicalc 21.9% 12.2%
Model 3: illness perceptionsd 24.4% 2.5%
Brief-IPQ (0–100) .060 .004 to.117 .195 .035
Model 4: pain catastrophizinge 25.6% 3.7%
PCS (0–52) .094 .022 to.167 .224 .011
Model 5: psychological distressf 22.0% 0.1%
HSCL-25 (1–4) .307 −1.305 to1.919 .035 .707
aUnstandardized Beta
bModel 1: sex, age, ethnicity, education and smoking
cModel 2: back pain (NRS), baseline RMDQ, baseline EQ-5D, clinical setting (GP or PT) and type of treatment (usual care or cognitive intervention) in addition to
the sociodemographic variables (model 1)
dModel 3: illness perceptions by the Brief IPQ (sum score) in addition to the variables in model 1 and 2
eModel 4: pain catastrophizing by the PCS (sum score) in addition to the variables in model 1 and 2
fModel 5:) psychological distress by the HSCL-25 (sum score) in addition to the variables in model 1 and 2
Løchting et al. Health and Quality of Life Outcomes  (2017) 15:40 Page 6 of 9
Study strengths and limitations
Study strengths include the a-priori secondary analysis
of a cluster RCT with the inclusion of the three main
types of PROs – specific, generic and individualized –
recommended for use in LBP research. It has been ar-
gued that prognostic variables should be evaluated in pa-
tients who have received the same treatment or have
been participants in a randomized trial [42]. The inclu-
sion of both sociodemographic, health/clinical and psy-
chological variables reflects the biopsychosocial model.
Respondent burden meant that only a selection of self-
completed instruments assessing psychological aspects
and outcomes could be included. The aims of the inter-
vention study informed instrument selection including
primary and secondary outcomes [19]. Instruments
assessing other psychological aspects that are relevant to
back pain patients including coping, fear avoidance be-
liefs and self-efficacy were not included. Moreover, the
prediction models in this study were the ones that best
suited our data, hence testing and validating the predict-
ive performance in other samples is necessary [43]. Fu-
ture studies should evaluate the psychometric properties
of the HSCL-25 in patients with LBP. Finally, there was
a loss to follow up of approximately 25%, which follows
previous research in back pain [5, 6].
Conclusions
Illness perceptions and pain catastrophizing predicted
12-months PRO scores including those for two of the
most widely applied specific and generic instruments,
the RMDQ and EQ-5D, as well as individualized out-
comes as assessed by the PGI. The latter has had consid-
erably less application but is recommended for back
pain research as a means of addressing the limitations of
current PRO instruments [13]. Differences were found
for the type of outcomes and the amount of variation
explained by the psychological instrument scores with
illness perceptions making the largest overall contribu-
tion. Further studies are needed to assess whether these
findings are replicated in other groups of patients with
LBP. Future studies should consider the inclusion of ill-
ness perceptions as a potential determinant of health
outcome as assessed by recommended PRO instruments
in addition to more traditional psychological aspects.
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